{"entity":{"id":"dong-a-st","kind":"company","name":"Dong-A ST","aka":["Dong-A ST Co., Ltd.","Dong-A Socio Holdings"],"tldr":"Dong-A ST is a Seoul pharmaceutical company, the prescription-medicine arm of one of Korea's oldest drug groups, which sponsors phase 3 cancer trials including biosimilars and supportive-care products.","summary":"Dong-A ST Co., Ltd. was formed in 2013 when the Dong-A group split its prescription business from its consumer arm. It develops and markets prescription medicines in Korea and abroad, including oncology supportive-care products, a pegylated G-CSF and biosimilars developed with partners, and it acts as lead sponsor of phase 3 cancer trials registered on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.donga-st.com"},{"label":"ClinicalTrials.gov: trials led by Dong-A ST Co., Ltd.","url":"https://clinicaltrials.gov/search?lead=Dong-A%20ST%20Co.%2C%20Ltd."},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q110114773"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Seoul","country":"KR","companyType":"pharma","website":"https://www.donga-st.com","founded":2013,"stage":"public","investors":[],"funding":[]},"route":"/companies/dong-a-st/","neighbours":{"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}